Tag: trimethoprim

Trimethoprim and Potassium Levels: How This Common Antibiotic Can Raise Your Risk of Hyperkalemia

Trimethoprim and Potassium Levels: How This Common Antibiotic Can Raise Your Risk of Hyperkalemia

Trimethoprim, found in Bactrim and Septra, can cause dangerous spikes in potassium levels, especially in older adults and those on blood pressure meds. Learn who’s at risk, how fast it happens, and what to ask your doctor.

RECENT POSTS

September 24, 2025
Flunil (Fluoxetine) vs. Popular Antidepressant Alternatives: A Complete Comparison

A detailed look at Flunil (Fluoxetine) compared with other antidepressants. Learn mechanisms, dosing, side‑effects, cost and how to pick the right option for you.

December 6, 2025
Never Use Household Spoons for Children’s Medicine Dosing: A Safety Guide

Using household spoons to dose children's medicine is dangerous and inaccurate. Learn why oral syringes and milliliter measurements are the only safe choice for kids' liquid medications.

November 13, 2025
Alcohol and Prescription Drugs: Dangerous Interaction Effects

Alcohol and prescription drugs can interact dangerously, causing overdose, liver damage, or death. Learn which meds are most risky, who's most vulnerable, and how to stay safe.

May 12, 2023
The Connection Between Calcium Acetate and Dental Health

As a dental health enthusiast, I recently learned about the fascinating connection between calcium acetate and dental health. Calcium acetate, a compound found in some dental products, helps to combat tooth decay and promote healthy gums. It works by neutralizing the acids in our mouth, which are responsible for breaking down tooth enamel. Additionally, calcium acetate aids in remineralizing our teeth, making them stronger and more resistant to cavities. Incorporating dental products containing calcium acetate into our oral hygiene routine can significantly improve our overall dental health.

March 14, 2026
Cystic Fibrosis: Genetic Respiratory Disease and New Therapies

Cystic fibrosis is a genetic disease causing thick mucus in the lungs and organs. New CFTR modulator drugs like Trikafta have transformed survival rates, but access and cost remain major barriers for many.